BioSpace News Archive

Genetown

Syros Announces Strategic Priorities and Expected Milestones

Potential Proof-of-Concept Data for SY-1425 in Combination with Azacitidine in RARA-Positive Relapsed or Refractory AML Patients Expected in Fourth Quarter of 2020

January 12, 2020
·
6 min read
Biotech Bay

Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones

In 2025, Company Expects to Have 4 Marketed Products in at Least 8 Indications, at Least 6 Molecules in Clinical Development and a Broad Research Pipeline

January 12, 2020
·
8 min read
Business

Exelixis Outlines Key Priorities and Anticipated Milestones for 2020-21, Announces Preliminary Fourth Quarter and Full Year 2019 Financial Results, and Provides 2020 Financial Guidance

Company announces anticipated timelines for data readouts from six cabozantinib potentially label-enabling clinical studies and up to three new potential IND candidates

January 12, 2020
·
21 min read
Business

Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance

Baxter International Inc. announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.

January 12, 2020
·
16 min read
Biotech Bay

Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook

OPTIC phase 1 trial progressing with plans to complete patient dosing in cohort three, begin enrollment in cohort four in 1Q20

January 12, 2020
·
6 min read
Skyrocketing growth tipped for China Medical industry over next 5 years; Medtec China 2020 upgrades to two halls to meet market needs

According to a forecast from CIConsulting, the revenue of China’s medical equipment and manufacturing industry will reach CNY327.4 billion in 2019, the average annual compound growth rate over the next five years will be about 8.15%, and the market will reach CNY447.9 billion in 2023.

January 12, 2020
·
3 min read
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC

Innovent Biologics, Inc. jointly announced with Eli Lilly and Company the results of a Phase 3 study in China; the ORIENT-11 trial of Tyvyt® in combination with ALIMTA® and platinum in first-line advanced or recurrent nonsquamous non-small cell lung cancer, without sensitive EGFR mutation or ALK rearrangement, met the predefined primary endpoint of progression-free survival in an interim analysis.

January 12, 2020
·
8 min read
Genetown

EQRx Launches to Create Innovative Medicines at Dramatically Lower Prices for People, Healthcare Systems and Society

Bolstered with $200M Series A Financing, EQRx Brings Blue-Chip Investors and Life Sciences Leaders Together to Re-Make the Business of Drug Discovery, Development and Delivery to Patients Led by Alexis Borisy as Chairman and CEO and Melanie Nallicheri as President and COO

January 12, 2020
·
4 min read
Business

Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year

Issues 2020 guidance of more than 725,000 samples accessioned and more than $330 million in revenue, reflecting a more than 50% annual growth in both volume and revenue

January 12, 2020
·
9 min read
Business

Hologic Announces Preliminary Financial Results for First Quarter of Fiscal 2020

Hologic, Inc. announced preliminary revenue results for its first fiscal quarter ended December 28, 2019.

January 12, 2020
·
5 min read